Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/164717
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Servi, Barbara-
dc.contributor.authorRanzini, Francesco-
dc.contributor.authorPiqué i Clusella, Núria-
dc.date.accessioned2020-06-08T06:27:13Z-
dc.date.available2020-06-08T06:27:13Z-
dc.date.issued2016-03-29-
dc.identifier.issn1746-0913-
dc.identifier.urihttp://hdl.handle.net/2445/164717-
dc.description.abstractAim: To evaluate whether Utipro(®), a natural product approved to prevent urinary tract infections, protects intestinal epithelial cells from Escherichia coli adherence/intracellular invasion in vitro. Materials & methods: Caco-2 and CacoGoblet(TM) cells were treated with Utipro (1.5 to 10 mg/ml) or untreated (controls). E. coli adherence/intracellular invasion was evaluated by Trans-Epithelial Electrical Resistance, Lucifer Yellow assay and microbial counts. Results: Utipro was noncytotoxic. Utipro 5 and 10 mg/ml protected cell tight junctions (mean ± SD Trans-Epithelial Electrical Resistance [Ω × cm(2)] 66.83 ± 0.29 and 71.33 ± 0.29, respectively), and protected cells from E. coli intracellular invasion (mean ± SD reductions in total bacteria counts [Log10] 0.9 ± 0.06 and 2.1 ± 0.56, respectively). Conclusion: Results indicate that Utipro creates a protective physical barrier on intestinal epithelial cells in vitro which reduces the settling of E. coli reservoirs. These results constitute the first step in the demonstration of the efficacy of Utipro to prevent urinary tract infections. Further research is needed in in vivo models and clinical trials.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFuture Medicine-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.2217/fmb-2016-0022-
dc.relation.ispartofFuture Microbiology, 2016, vol. 11, p. 651-658-
dc.relation.urihttps://doi.org/10.2217/fmb-2016-0022-
dc.rights(c) Future Medicine, 2016-
dc.subject.classificationFarmacologia-
dc.subject.classificationMicrobiologia-
dc.subject.classificationInfeccions per escheríchia coli-
dc.subject.classificationCèl·lules epitelials-
dc.subject.classificationFisiologia-
dc.subject.classificationInfeccions del tracte urinari-
dc.subject.classificationAdherència bacteriana-
dc.subject.otherPharmacology-
dc.subject.otherMicrobiology-
dc.subject.otherEscherichia coli infections-
dc.subject.otherEpithelial cells-
dc.subject.otherPhysiology-
dc.subject.otherUrinary tract infections-
dc.subject.otherBacterial adhesion-
dc.titleEffect of Utipro® (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec659100-
dc.date.updated2020-06-08T06:27:14Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)

Files in This Item:
File Description SizeFormat 
659100.pdf449.35 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.